Communiqués Avedro, Inc.

Actions

AVDR

US05355N1090

Equipement, fournitures et distribution médicale

Temps Différé Nasdaq Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		+0,61%	-

07/08/19	Avedro, Inc. annonce des résultats non audités pour le deuxième trimestre et le semestre clos le 30 juin 2019 ; révise les prévisions de chiffre d'affaires pour l'ensemble de l'exercice 2019.	CI
15/05/19	Transcript : Avedro, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 05:15 PM

Communiqués

09/09/20	INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm	BU
08/09/20	INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm	BU
21/11/19	AVEDRO INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
18/11/19	AVEDRO INC : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/11/19	Avedro, Inc. Announces Third Quarter 2019 Financial Results	GL
09/10/19	Avedro Announces Schedule of Events at the American Academy of Ophthalmology Annual Meeting	GL
28/09/19	AVEDRO, INC. SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces an Investigation of Avedro, Inc. (AVDR) Over the Proposed Merger of the Company with Glaukos Corporation	PR
11/09/19	Boost Epi-On™ Corneal Cross-Linking Data to Be Presented at the 37th Congress of the ESCRS	GL
13/08/19	AVEDRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avedro, Inc. - AVDR	BU
09/08/19	Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Avedro, Inc. (NASDAQ: AVDR) on Behalf of Avedro Shareholders and Encourages Avedro Investors to Contact the Firm	PR
08/08/19	Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Avedro, Inc. has obtained a Fair Price in its sale to Glaukos Corporation	PR
07/08/19	Avedro, Inc. Announces Second Quarter 2019 Financial Results	GL
25/07/19	Avedro, Inc. to Report Second Quarter 2019 Financial Results on August 8, 2019	GL
09/05/19	Avedro, Inc. Announces First Quarter 2019 Financial Results	GL
30/04/19	Avedro, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference	GL
22/04/19	Avedro to Present Research on Proprietary Corneal Cross-Linking Technologies at 2019 ARVO Annual Meeting	GL
05/04/19	UPDATE -- Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus	GL
05/04/19	Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus	GL
13/03/19	Avedro, Inc. Announces Appointment of Patrick B. Jacques as Vice President of Sales	GL
28/02/19	Avedro, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on March 21, 2019	GL